How safe are stem cell treatments at foreign clinics?
Unregulated stem cell treatments at foreign clinics carry real risks, including infections, tumour formation and financial harm. Only proceed with a treatment that holds official registration, and discuss this in advance with a specialist.
Infection, rejection of cell material and the development of tumours are the most serious risks described in connection with unregulated stem cell treatments at foreign clinics. The majority of these clinics are located in low- and middle-income countries. Exact figures on how often complications occur are lacking, but the harm is both physical and financial and has been documented in multiple analyses.
A website analysis of 68 clinics in 21 countries illustrates how misleading the marketing is: 88% claim that the treatment works, yet only a quarter share actual outcome data. Only 12% advised patients to consult their own doctor. Not a single clinic recommended a travel health consultation or vaccinations before the treatment trip. There is also no guarantee that you will receive the promised treatment or the correct number of cells, and follow-up care is virtually non-existent.
A particular risk applies to one widely used cell type: mesenchymal stem cells. In some studies these actually promote tumour growth and metastasis rather than bringing about a cure. This risk has not yet been precisely quantified, but researchers consider it real. The therapeutic potential of these cells is regarded in the scientific literature as overstated.
Regulation varies considerably from country to country. In Latin America, Mexico does not authorise any stem cell therapy, while Brazil and Argentina do have some degree of regulation. In Canada and comparable countries rules exist, but enforcement falls short: clinics making false claims are rarely sanctioned. Physicians who offer such treatments are thereby acting in conflict with the requirement for evidence-based medicine.
It is important to distinguish that not all cell therapy is the same. Treatments such as bone marrow transplantation and CAR-T therapy (an advanced immunotherapy for certain cancers) are scientifically well supported and strictly regulated. Unregulated stem cell tourism also falls under the heading of 'medical tourism', but the safety profiles are fundamentally different. Anyone considering travelling abroad for a stem cell treatment would do well to check whether the treatment holds official registration in the country concerned, and to discuss this with a specialist at home.
This answer draws on multiple review studies and a website analysis of 68 clinics in 21 countries. The review studies describe complications and regulatory problems in broad terms, but rarely report exact frequencies of harm. No studies are available in which participants were randomly assigned, which makes establishing a direct causal relationship difficult. The pattern of risks is, however, consistent across the different sources.